ITGB5 and pancreatic adenocarcinoma: As shown in Figure 5A–5C, PAAD patients with high expression of ITGB1, ITGB5, and OSMR had poorer outcomes, while patients in down-regulation of ITGB1, ITGB5, and OSMR group showed a higher survival rate (P < 0.05).